| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.018 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |